Tag: Afrezza
MannKind regains marketing rights to inhaled insulin
The drug went on sale in early 2015, but original and current marketer Sanofi had difficulty in marketing it effectively.
Danbury’s MannKind delivers inhalable insulin
MannKind of Danbury has developed a rapid-acting insulin inhalant called Afrezza.
